A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures

Clinical trial NCT03116828 · COMPLETED

Trial details

NCT number: NCT03116828
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Epilepsy With Partial On-set Seizures

Start date: 2017-07-07
Primary completion: 2019-06-06
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.